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MRA Contrast Bolus Timing
With Ultrasound Bubbles
Martin R. Prince, MD, PhD,* Yoshimi Anzai, MD, Mohammed Neimatallah, MD,
Qian Dong, MD, and Jonathan M. Rubin, MD, PhD
The purpose of this study was to determine the feasibility
of using an ultrasound contrast agent test bolus to deter-
mine optimum bolus timing for three-dimensional (3D)
gadolinium (Gd)-enhanced magnetic resonance angiogra-
phy (MRA). Small test doses of ultrasound contrast agent
(0.3 ml Optison) were injected intravenously followed imme-
diately by a 20 ml saline flush. Arrival of the contrast agent
was detected by spectral Doppler ultrasound (US). This
technique was implemented in patients undergoing periph-
eral vascular MRA and carotid MRA. Arrival of the US
contrast agent test bolus was readily detected by the
change in amplitude of the Doppler spectrum and by a huge
increase in the audio signal amplitude. This contrast travel
time measurement accurately guided bolus timing for 3D
Gd MRA. Bolus timing for 3D contrast-enhanced MRA can
be performed using US, thereby eliminating the problems
and MR scanner time required for injecting a test bolus of
Gd contrast. J. Magn. Reson. Imaging 1999;10:389–394.
r 1999 Wiley-Liss, Inc.
Index terms: ultrasound contrast; gadolinium; MR angiogra-
phy; peripheral vascular disease; carotid artery; atherosclero-
sis
THREE-DIMENSIONAL, contrast-enhanced magnetic
resonance angiography (MRA) is increasingly used for
diagnosing vascular pathology because of its relatively
low risk and expense compared with conventional arte-
riography (1–3). This technique requires timing of the
intravenous contrast injection so that imaging is per-
formed while contrast is in the vessel of interest. Usu-
ally, this is during the arterial phase of the bolus in
order to image the arteries without the confounding
effects of venous enhancement. Several strategies have
emerged for optimizing bolus timing. These include a
‘‘best guess’’ based on patient history, fluoroscopic (4) or
automatic triggering (5,6), ultrafast imaging (7,8), and
use of a test bolus (9,10). The ‘‘best guess’’ approach
works well when combined with a large contrast dose
infused over a sufficiently longer time to compensate for
timing errors. Floroscopic and automatic triggering and
ultrafast multiphase imaging require specialized hard-
ware and software. The test bolus approach has a
simple logic and can be used on any scanner. For these
reasons, the test bolus is one of the more popular
approaches. A small amount of additional contrast and
additional scanner time are required for the test bolus,
but the improvement in consistency of MRA image
quality often makes this a worthwhile trade-off.
This study investigates the feasibility of optimizing
MRA contrast bolus timing by using ultrasound to
detect an ultrasound contrast agent instead of gadolin-
ium. This method of determining contrast bolus timing
can be performed prior to entering the magnet, thereby
reducing the MR scanner time. It eliminates unwanted
enhancement of background tissues caused by a gado-
linium test bolus. It also allows all the gadolinium
contrast to be used for the actual MRA sequence. One
final advantage is that it can be easily repeated multiple
times if there is uncertainty about the results from the
first test bolus measurement or if it is necessary to
measure the contrast travel time to a number of differ-
ent vessels of interest.
MATERIALS AND METHODS
A standard ultrasound unit (Diasonics, San Jose, CA)
was used with 3.5 curved linear array or 5 MHz linear
array transducers depending on the vessels being inter-
rogated. Initially gray scale and color flow imaging was
used to find the artery or vein of interest. Then spectral
Doppler mode was used to obtain flow velocity informa-
tion via both audio and spectral presentation. The
initial Doppler gain was set at as low a level as possible
to guarantee continuous detection and yet maximize
dynamic range. A large dynamic range was necessary to
allow detection of both the initial bolus arrival and the
bolus peak. Since scanning was performed near a suite
of three operating magnets, there was considerable
radio frequency (RF) interference in the line voltage that
was visible in the Doppler spectrum. A high wall filter
setting helped suppress this RF noise. The change in
ultrasound signal upon arrival of the ultrasound con-
trast agent was so prominent that this high filter setting
was not a significant problem. We did not limit ourselves
to scanning at low mechanical indexes since we were
only interested in the first pass of the bubbles, and
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bubble destruction was to our benefit if we needed to
perform further injections.
This study was approved by the hospital institutional
review board, and all patients gave written informed
consent before participating. After obtaining consent,
the artery of interest was localized on ultrasound, and a
dose of 0.3-ml ultrasound contrast agent (Optison,
Mallinckrodt, St. Louis, MO) was introduced into the IV
tubing within 20 cm of the IV site. This dose, which is
less than the lowest recommended dose (0.5 ml) in the
package insert, was chosen based on prior experience
with this agent. The ultrasound contrast agent was then
advanced into the bloodstream by flushing 20-ml nor-
mal saline through the intravenous line at a rate of 2
ml/sec. The arrival of this ultrasound contrast agent in
the vessel of interest was noted by listening for a change
in the audio amplitude of the Doppler signal and by
visualizing a change in the Doppler frequency spectrum
(see Fig. 2). The time of arrival of the leading edge of the
bolus and the time to the peak of the bolus were both
noted. The time to peak was defined as the point when
the spectral display first saturated.
For peripheral vascular studies the contrast travel
time was measured at the aorta (Fig. 1), the common
femoral artery, and the popliteal artery. For carotid
artery imaging the contrast travel time was measured at
the common carotid artery proximal to the carotid
bifurcation (Fig. 2) and the internal jugular vein (Fig. 3)
on the side corresponding to the patient’s symptoms.
For portal venous studies the contrast travel time was
measured to the abdominal aorta and also to the portal
vein. Whenever there was any difficulty determining the
contrast travel time precisely, the injection was re-
peated after a delay of 3–4 minutes to allow clearance of
the agent that had already been injected.
Bolus Chase Peripheral MRA
All imaging was performed on a 1.5 T magnet (LX
Horizon, GE Medical Systems, Waukesha, WI) equipped
with echoplanar gradients. The body coil was used for
signal transmission and reception. After the ultrasound
measurement of contrast travel times, the patient was
positioned supine and feet first on the scanner table.
The ankles and knees were elevated with cushions so
the arteries of the legs were horizontally aligned with the
aorta. By landmarking on the sternum and disengaging
the table from the drive mechanism, the ‘‘dog house’’
moved out the back end of the magnet, allowing free
manual movement of the table from the abdomen down
to the ankles.
Ten axial two-dimensional time-of-flight (2D TOF)
localizer slices were obtained spread out from mid-
abdomen to mid-calf by manually moving the table
about 10 cm in between acquisition of each slice. Then
the table was manually positioned for imaging the pelvis
and abdomen, and a sagittal single-shot fast spin-echo
(SSFSE) localizer sequence was obtained.
A 3D fast spoiled gradient-echo volume acquisition
was prescribed using the sagittal SSFSE and axial 2D
TOF localizer images to determine the optimal anterior
and posterior coverage. The following parameters were
utilized: TR/TE 6/2.1 msec, flip angle 45°, bandwidth
32 kHz, field of view 44 cm, and 36 partitions, each 3
mm thick with zero filling interpolation to obtain a total
of 60 coronal images per 3D volume. The acquisition
time was 30 seconds for each 3D volume of MRA data.
Three seconds were required to move the table from
station 1 (abdomen-pelvis) to station 2 (thigh), and
another 3 seconds were needed to move from station 2
(thigh) to station 3 (calf). Thus, the total imaging time
was 96 seconds.
A positioning pole was used to fix the table precisely at
each of the three stations to ensure that the precontrast
and during contrast images were acquired at exactly the
same table locations, thereby allowing digital subtrac-
tion. To minimize the total amount of table motion, the
precontrast, 3D volumes of data (used as a mask for
subtraction) were obtained in reverse order starting at
the calf, then the thigh, and finally the abdomen/pelvis.
This was followed by contrast injection and acquisition
Figure 1. Spectral Doppler ultrasound of the abdominal aorta
pre (top) and post (bottom) microbubbles shows the character-
istic increase in spectral Doppler signal upon arrival of the
bolus.
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of the same three stations beginning at the abdomen/
pelvis, then the thigh, and finally the calf all during the
arterial phase of the bolus.
Before initiating contrast injection, the optimum con-
trast injection rate and delay time were calculated as
follows:
scan delay 5 time to aorta peak bolus 2 scan time/4
gadolinium bolus duration 5 2.5
3 scan time 1 table movement time
2 (popliteal peak time 2 aortic peak time)
2 ultrasound bolus duration.
The scan delay is defined as the time between initiating
the injection and initiating the scan. The injection rate
was determined by taking the total volume of gadolin-
ium to be administered to the patient based on a dose of
0.3 mmol/kg divided by the injection duration. After a
few cases, however, we found it was easier simply to give
every patient 60 ml. Ordering of k-space was adjusted to
acquire central k-space data for the first station toward
the end of the first acquisition. This was done by
selecting 0.5 averages, (partial Fourier imaging). Thus,
the central half of k-space was acquired during the
second half of the acquisition. The injection was then
timed to have contrast reach peak concentration at
about 15 seconds (midway) into the scan. Immediately
following this first acquisition of 3D coronal data, a
control variable (phorder) was changed in order to
activate centric phase encoding. In this way, the second
and third stations acquired data centrically with the
center of k-space at the very beginning of the scan. This
reduced the injection duration required and also re-
duced venous enhancement on the third station. The
total duration of bolus required was also reduced by
taking advantage of the delayed arrival of the contrast in
the calf compared with its arrival in the aorta. These
factors are all incorporated into the above equations.
Following acquisition of the three stations of data,
digital subtraction of the precontrast image data was
performed on a computer workstation (Advantage Win-
dows, GE Medical Systems). Performing digital subtrac-
tion on this computer workstation required all acquisi-
Figure 2. Spectral Doppler ultrasound of the common carotid
artery pre (top) and post (bottom) microbubbles shows the
characteristic increase in spectral Doppler signal upon arrival
of the bolus.
Figure 3. Spectral Doppler ultrasound of the internal jugular
vein shows a typical venous pattern pre (top) and post (bottom)
microbubbles with the typical increase in signal upon arrival of
the bolus.
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tions to be within the same series with no change in the
acquisition parameters other than the ordering of k-
space. Accordingly, care was taken during acquisition
to ensure that all 3D volumes of data were within the
same series. The initial prescanning was performed in
the abdomen, as this was felt to be the most likely
location to produce acceptable transmit and receiver
gain settings for all three stations.
Carotid MRA
Contrast bolus timing considerations were different for
carotid arteries compared with peripheral arteries. The
rapid transit time through the cerebrovascular circula-
tion and the low contrast extraction in the brain second-
ary to the blood-brain barrier tended to result in en-
hancement of the internal jugular veins, which obscured
visualization of the carotid arteries. To avoid this prob-
lem of jugular venous enhancement, the gadolinium
bolus was timed so that central k-space data were
acquired while contrast was in the carotid arteries but
not yet in the internal jugular veins. This required
measuring the contrast travel time to reach the carotid
arteries and the internal jugular veins. We used the
ultrasound technique as described above to measure
the time to arrival of the bubbles and also the time to the
peak contrast effect in both common carotid artery and
internal jugular vein.
Because of the potential for ringing artifacts with
centric phase encoding, sequential mapping of k-space
was employed. With sequential mapping of k-space, the
central, low spatial frequential lines of k-space data are
acquired in the middle of the scan. Actually they may be
slightly offset from the middle of the scan by a fraction of
a second due to the dummy (disdaq) pulses used at the
beginning of the scan, which are meant to bring the
tissue into dynamic equilibrium. Based on the ultra-
sound contrast travel time measurements, the bolus
was initially timed so that contrast was arriving in the
internal jugular vein 1 second after the mid-point of the
scan as follows:
scan delay 5 time to arrive in internal jugular vein
2 (scan time/2 1 1).
Then we checked to be sure the peak carotid time would
arrive well before the center of k-space. However, this
resulted in excessive internal jugular venous enhance-
ment and did not synchronize maximum arterial en-
hancement with the center of k-space. Accordingly, we
adjusted the algorithm to synchronize the center of
k-space with the center of the arterial peak. By keeping
the total scan time under 30 seconds, jugular venous
enhancement was not a problem. Thus,
carotid artery peak time # scan delay
1 scan time/2 2 1.
After deciding on the scan time, scan delay, and gadolin-
ium contrast agent dose, the infusion duration and
infusion rate were determined by setting the infusion
duration to half of the scan duration and the rate equal
to the dose divided by the infusion duration as follows:
infusion duration 5 scan duration/2
infusion rate 5 dose/infusion duration.
Eventually, to simplify and standardize all these param-
eters, we settled on a dose of 40 ml for all patients and a
scan duration of 24–28 seconds. This scan duration
required a difference between the peak carotid artery
time and jugular venous arrival time of at least 7
seconds, which was just barely possible in most pa-
tients.
For carotid arteries, imaging was performed using a
neurovascular head and neck coil (MRI Devices, Milwau-
kee, WI) designed to cover sufficiently inferiorly to
include all the way down to the aortic arch with ad-
equate signal-to-noise ratio. Coronal 3D gadolinium
MRA with a fast spoiled gradient-echo pulse sequence
was prescribed with the following parameters: TR/TE
6.2/1.4 msec, flip angle 45°, bandwidth 31.2 kHz, field
of view 26–27 cm, and 30 partitions, each 2.2 mm thick.
The acquisition time was 26 seconds for each 3D
volume of MRA data. The scan was repeated at least
twice to obtain arterial and venous phases.
RESULTS
Reliable ultrasound contrast arrival determinations were
made in the aorta, carotids, internal jugular vein, com-
mon femoral artery, and popliteal artery. The effect of
the bubbles on the ultrasound signal disappeared in
3–4 minutes so repetition of the measurement was not
degraded by a prior injection. In general, if it was
difficult to find the vessel of interest for the first measure-
ment, it became very easy to find during the equilibrium
phase of the bubbles, making a repeat measurement
easier to perform.
MRA based on these ultrasound test bolus timing
measurements produced perfect arterial phase images
in the most recent patients (Figs. 4, 5). However, in the
initial patients, a number of difficulties were encoun-
tered, as described below.
Arm Position
For peripheral MRA, the contrast travel time determina-
tion was performed with the arm at the patient’s side,
but MRA was performed initially with the arm elevated
over the patient’s head. In one patient, late arrival of the
gadolinium was hypothesized to have been caused by
the elevated arm pinching and obstructing the axillary/
subclavian vein and slowing down the bolus compared
to when it was measured by ultrasound. In subsequent
patients we have had the patient keep the arms crossed
over the abdomen and used a larger field of view instead
of placing the arms overhead, to avoid arm wraparound
artifact.
Injector Failure
In two patients, our mechanical injector stopped prema-
turely, once because of an inadequate battery charge
and a second time because of sensing excessive resis-
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tance. In a third patient, we forgot to account for the
dead space in the IV tubing. This caused an additional
delay between activating the injector and when contrast
actually began entering the arm vein. Switching to hand
injection with a standardized IV tubing set (SmartSet,
Topspins Inc., Ann Arbor, MI) eliminated these injector
problems. With hand injection, a 20-gauge angiocath-
eter was necessary for carotid MRA to make it easy to
inject at 2 ml/sec. For peripheral vascular bolus-chase
MRA, a 22-gauge angiocatheter seemed to provided the
optimal resistance to make a slower, 1-ml/sec infusion
rate easy to perform.
Multiple Intravenous Lines
In one patient with multiple IV lines, a contrast bolus
timing error was attributed to using different IV sites for
the ultrasound bolus timing measurement and subse-
quent gadolinium injection for MRA.
Claustrophobic Patient
One patient could not tolerate being inside the bore of
the magnet for more than a few minutes at a time.
During the confusion of pulling her out of the magnet
every 1–2 minutes, we inadvertently started her periph-
eral MRA at the middle station (thigh) instead of the
abdomen/pelvis. Bolus timing optimized for the abdo-
men/pelvis did not work for the thigh.
Difference Between Arrival and Peak
The ultrasound was so sensitive to the bubbles that it
was easy to identify the leading edge of the bolus but
more difficult to identify the bolus peak. This was
because the ultrasound signal quickly became fully
saturated. However, for MRA, the time to the peak of the
test bolus was more important than its arrival time. To
make it easier to identify the peak, it was helpful to
reduce the scanner gain. Reduced gain increased the
dynamic range, thereby reducing the problem of satura-
tion and making it easier to identify the peak of the
Figure 4. Bolus-chase peripheral MRA obtained with an 11
second scan delay, 58 second bolus duration, 0.7 ml/sec Gd
injection rate for a Gd dose of 40 ml and a scan time of 30
seconds per station. These parameters were based on ultra-
sound bolus timing measurements of aorta peak time 5 26
seconds, femoral artery time 5 33 seconds, and popliteal artery
time 5 38 seconds. Note the optimum arterial phase of the
bolus at all three stations.
Figure 5. Arterial phase carotid MRA obtained during a 28
second breath-hold with injection of 40 ml gadolinium timed
based upon ultrasound measurement of the contrast travel
time.
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bolus. However, in spite of adjusting the gain, satura-
tion always occurred at these doses of ultrasound
contrast agent. We wanted to determine contrast bolus
duration, but this proved elusive. Ultrasound was so
sensitive that the duration was tens of seconds for every
injection.
DISCUSSION
Optimizing contrast bolus timing has been a particu-
larly challenging aspect of 3D contrast-enhanced MRA.
Considerable effort has gone into developing techniques
whereby the scanner can precisely determine the con-
trast travel time to the vessel of interest. These data
demonstrate a method using ultrasound contrast that
can be performed prior to bringing the patient into the
magnet. It can also be repeated multiple times at
multiple different locations without accumulating gado-
linium contrast in the background tissues. Although
there were errors in the initial patients, subsequent
refinements allowed this technique to time contrast
infusions reliably for MRA.
MRA is not the only type of examination that might
benefit from using ultrasound to measure contrast
travel times. Computed tomography angiography could
also benefit from this technique, especially with ultra-
fast, multidetector scanners that can do the chest,
abdomen, and pelvis in a single breath-hold. It would be
useful to know the time to reach aortic arch, suprarenal
abdominal aorta, and infrarenal abdominal aorta to
avoid having a fast scanner get ahead of the bolus. This
might be especially important in patients who have slow
flow such as those with aneurysmal disease or a history
of congestive heart failure. Liver, breast, pelvis, and
functional MRI may also benefit from knowing the
contrast travel time before beginning the examination.
To obtain abdominal arterial and portal venous phases,
it may be helpful to use the time to aorta and time to
portal vein to help decide how short to make the arterial
phase acquisition so it is still possible to catch the portal
venous phase.
Cost may be a problem with using ultrasound con-
trast agents because they tend to be expensive. The
agent used in this study costs $110 per 3-ml vial.
However, a vial has enough agent for 10 measurements,
so if there were several patients in a row this may be
economical. Another possibility is to use carbon dioxide
bubbles. Even air can be mixed with saline to form
bubbles that are safe for intravenous injection. How-
ever, these bubbles may only be useful for measure-
ments up to the pulmonary circulation because they
tend to be dissipated in the lungs.
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